RxDoctor Payments Data

John Paul Gomez, MD

Child & Adolescent Psychiatry · Bethlehem, PANPI 1811958366

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.

$1,767in general payments, 2019–2025

Across 68 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$381
  • Johnson & Johnson$273
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$247
  • Alkermes, Inc.$167
  • Teva Pharmaceuticals USA, Inc.$164
  • E.r. Squibb & Sons, L.L.C.$141
  • plus $393 from 8 others

What the payments were for

  • Food & beverage$1,767100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,767 in reported general payments places this provider in the 80th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.

See all child & adolescent psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,475
Medicare patients
15
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quillivant XrMethylphenidate Hcl11$10,349
Clozapine51$2,594
Methylphenidate ErMethylphenidate Hcl13$2,017
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$1,404
Buspirone Hcl12$971
Haloperidol Lactate15$869
Guanfacine Hcl ErGuanfacine Hcl19$865
Methylphenidate Hcl21$521
Benztropine Mesylate23$314
Paroxetine Hcl12$304
Clonazepam18$302
Fluoxetine Hcl33$280
Hydroxyzine Hcl14$160
Risperidone18$96
Topiramate12$56

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Bethlehem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →